H3K9me3 Inhibition Improves Memory, Promotes Spine Formation, and Increases BDNF Levels in the Aged Hippocampus
Overview
Authors
Affiliations
Significance Statement: Cognitive decline is a debilitating condition associated with not only neurodegenerative diseases but also aging in general. However, effective treatments have been slow to emerge so far. In this study, we demonstrate that epigenetic regulation of key synaptic proteins may be an underlying, yet reversible, cause of this decline. Our findings suggest that histone 3 trimethylation is a probable target for pharmacological intervention that can counteract cognitive decline in the aging brain. Finally, we provide support to the hypothesis that, by manipulating the enzyme that regulates H3K9me3 (using a newly developed specific inhibitor of SUV39H1), it is possible to alter the chromatin state of subjects and restore memory and synaptic function in the aging brain.
Epigenetic regulation of TDP-43: potential implications for amyotrophic lateral sclerosis.
Mengistu D, Terribili M, Pellacani C, Ciapponi L, Marzullo M Front Mol Med. 2025; 5:1530719.
PMID: 40017539 PMC: 11865237. DOI: 10.3389/fmmed.2025.1530719.
Loss of H3K9 trimethylation leads to premature aging.
Mrabti C, Yang N, Desdin-Mico G, Alonso-Calleja A, Vilchez-Acosta A, Pico S Res Sq. 2025; .
PMID: 39764087 PMC: 11702797. DOI: 10.21203/rs.3.rs-4012025/v1.
The impact of sex on memory during aging and Alzheimer's disease progression: Epigenetic mechanisms.
Scheinman S, Dong H J Alzheimers Dis. 2024; 102(3):562-576.
PMID: 39539121 PMC: 11721493. DOI: 10.1177/13872877241288709.
Loss of H3K9 trimethylation leads to premature aging.
Mrabti C, Yang N, Desdin-Mico G, Alonso-Calleja A, Vilchez-Acosta A, Pico S bioRxiv. 2024; .
PMID: 39091811 PMC: 11291141. DOI: 10.1101/2024.07.24.604929.
Targeting neuronal epigenomes for brain rejuvenation.
Zocher S EMBO J. 2024; 43(16):3312-3326.
PMID: 39009672 PMC: 11329789. DOI: 10.1038/s44318-024-00148-8.